News

NPL wins £230,000 grant to scale trapped-ion quantum chips

What's the deal? The National Physical Laboratory (NPL)Dealroom has a profile for this one. Try Dealroom → has secured a £230,000 grant from the Government Office for Technology Transfer (GOTT)Dealroom has a profile for this one. Try Dealroom → to develop next-generation trapped-ion quantum computing technologies. The money targets one of the sector's biggest barriers to commercial adoption: scalability.

What does NPL do? The UK lab has built a microfabricated, chip-scale ion microtrap that confines and manipulates arrays of ions — a platform prized for its fidelity, stability, and scalability. Its devices already support research at NPL and the University of Oxford.

What's the money for? The new project will tackle the manufacturing bottlenecks that limit large-scale production of ion trap devices. The funding supports a batch packaging process to improve production yield in the final stages of fabrication.

What's the endgame? NPL wants to move from lab research to deployable systems by enabling reliable production at scale. That, it says, is a step towards networked, interconnected quantum computers that overcome the limits of single-node machines.

Why now? An earlier GOTT grant put an NPL microtrap system into the National Quantum Computing Centre — the first trapped-ion demonstration in its labs. This follow-on grant builds on that work.

"The next challenge is ensuring that breakthrough technologies can be manufactured and deployed at scale," said Cyrus Larijani, programme director for NPL Quantum. He added the project will help build "a resilient UK quantum supply chain."

The signal: Quantum funding is shifting from pure research towards scaling hardware and infrastructure, from PsiQuantum's $1 billion Series E to proposed US incentives worth $2 billion. NPL's grant is small by comparison, but its focus on manufacturing yield — not a general promise of quantum progress — mirrors where the market is heading.

Read more: npl.co.uk

Image credit: jurvetson

More top stories